Supplementary data

Published: 14 August 2019| Version 1 | DOI: 10.17632/6m4ghzt666.1
Contributor:
Da-Ae Yu

Description

Supplementary data for the publication by Yu DA et al. Oral Janus kinase inhibitors for the treatment of alopecia areata: a systematic review and meta-analysis. Supplemental Fig 1. PRISMA flow diagram. Supplemental Table I. Main characteristics of studies on oral tofacitinib and ruxolitinib for the treatment of alopecia areata Supplemental References

Files

Categories

Alopecia Areata

License